ALHC

Alignment Healthcare, Inc. NASDAQ

Healthcare ·Medical - Healthcare Plans ·US · alignmenthealthcare.com

$20.26

Mkt Cap $4.0B

52w Low $11.62 70.5% of range 52w High $23.87

50d MA $19.39 200d MA $18.09

P/E (TTM) -5475.7x

EV/EBITDA 81.1x

P/B 22.4x

Debt/Equity 1.9x

ROE -0.4%

P/FCF 34.6x

RSI (14) —

ATR (14) —

Beta 1.20

50d MA $19.39

200d MA $18.09

Avg Volume 3.1M

About

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada. It also coordinates and provides covered health care se…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 30, 2026	AMC	0.01	0.05	+400.0%	22.54	-6.3%	-10.1%	—	—	—	—	—	—
Feb 26, 2026	AMC	-0.15	-0.05	+66.7%	20.42	-7.7%	-5.9%	-3.8%	-9.6%	-7.5%	-9.1%	-17.5%	—
Oct 30, 2025	AMC	-0.01	0.02	+300.0%	17.12	+8.2%	-1.5%	-1.6%	-0.2%	-0.4%	-3.7%	+11.4%	—
Jul 30, 2025	AMC	-0.07	0.07	+200.0%	13.00	+15.4%	+6.0%	-0.2%	+5.1%	+3.2%	+5.5%	+25.8%	—
May 1, 2025	AMC	-0.12	-0.05	+58.3%	16.77	+1.7%	-7.4%	-7.7%	-6.3%	-7.5%	-8.1%	-7.5%	—
Feb 27, 2025	AMC	-0.18	-0.16	+11.1%	13.47	+11.8%	+16.5%	+15.2%	+16.9%	+17.4%	+13.2%	+38.2%	—
Oct 29, 2024	AMC	-0.14	-0.14	+0.0%	11.71	+0.0%	+0.2%	+5.9%	+10.6%	+13.5%	+13.4%	+7.7%	—
Aug 1, 2024	AMC	-0.14	-0.13	+7.1%	8.62	+3.8%	+3.7%	+2.4%	+6.4%	+1.5%	-2.3%	+13.8%	—
May 2, 2024	AMC	-0.24	-0.25	-4.2%	5.26	+8.7%	+26.0%	+28.9%	+30.6%	+28.9%	+31.4%	+51.9%	—
Feb 27, 2024	AMC	-0.22	-0.25	-13.6%	6.92	-5.3%	-18.2%	-13.3%	-18.5%	-22.0%	-21.0%	-28.3%	—
Nov 2, 2023	AMC	-0.19	-0.19	+0.0%	6.35	+6.1%	-5.2%	-8.0%	-2.7%	-1.6%	-6.9%	+17.8%	—
Aug 3, 2023	AMC	-0.21	-0.15	+28.6%	5.78	+14.5%	+11.6%	+12.6%	+14.7%	+14.9%	+13.0%	+0.2%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 1	UBS	Maintains	Neutral → Neutral	—	$22.54	$21.12	-6.3%	-10.1%	—	—	—	—
May 1	Barclays	Maintains	Equal Weight → Equal Weight	—	$22.54	$21.12	-6.3%	-10.1%	—	—	—	—
Feb 5	JP Morgan	Maintains	Overweight → Overweight	—	$21.33	$21.53	+0.9%	-0.8%	+2.0%	-2.7%	-3.3%	-4.4%
Jan 16	TD Cowen	Maintains	Buy → Buy	—	$22.50	$22.48	-0.1%	+0.0%	+1.1%	+3.6%	+4.9%	+5.8%
Jan 14	UBS	Maintains	Neutral → Neutral	—	$20.92	$20.99	+0.3%	+4.0%	+7.6%	+7.6%	+8.7%	+11.4%
Jan 6	Piper Sandler	Maintains	Overweight → Overweight	—	$21.00	$21.45	+2.1%	+1.4%	-0.3%	-0.2%	-1.0%	+1.3%
Dec 17	JP Morgan	Maintains	Overweight → Overweight	—	$20.03	$20.07	+0.2%	+2.6%	+1.9%	+1.9%	+0.8%	-2.5%
Nov 24	JP Morgan	Upgrade	Neutral → Overweight	—	$16.70	$17.38	+4.1%	+5.5%	+14.6%	+15.1%	+15.0%	+14.3%
Nov 5	JP Morgan	Maintains	Neutral → Neutral	—	$17.09	$16.96	-0.8%	-0.2%	-3.5%	-4.4%	-4.2%	-3.6%
Nov 3	Barclays	Maintains	Equal Weight → Equal Weight	—	$16.86	$17.00	+0.8%	-0.1%	+1.4%	+1.2%	-2.2%	-3.1%
Oct 31	UBS	Maintains	Neutral → Neutral	—	$17.12	$18.53	+8.2%	-1.5%	-1.6%	-0.2%	-0.4%	-3.7%
Aug 25	KeyBanc Capital Markets	Upgrade	Sector Weight → Overweight	—	$15.84	$16.23	+2.5%	-1.6%	-1.0%	+1.9%	+3.0%	+3.3%
Jul 31	Barclays	Upgrade	Underweight → Equal Weight	—	$13.00	$15.00	+15.4%	+6.0%	-0.2%	+5.1%	+3.2%	+5.5%
May 2	UBS	Maintains	Neutral → Neutral	—	$16.77	$17.05	+1.7%	-7.4%	-7.7%	-6.3%	-7.5%	-8.1%
Apr 15	Baird	Maintains	Outperform → Outperform	—	$19.13	$19.52	+2.0%	+1.6%	+1.8%	-4.7%	-8.5%	-5.1%
Apr 8	Stifel	Maintains	Buy → Buy	—	$17.82	$19.73	+10.7%	+6.3%	+4.0%	+11.0%	+10.8%	+7.4%
Mar 6	JP Morgan	Maintains	Neutral → Neutral	—	$15.81	$15.65	-1.0%	-3.5%	-5.8%	-5.0%	-2.5%	-0.6%
Mar 4	BofA Securities	Maintains	Buy → Buy	—	$15.52	$15.53	+0.1%	+1.5%	+1.9%	-1.7%	-4.1%	-3.2%
Mar 4	Piper Sandler	Maintains	Overweight → Overweight	—	$15.52	$15.53	+0.1%	+1.5%	+1.9%	-1.7%	-4.1%	-3.2%
Feb 28	Stifel	Maintains	Buy → Buy	—	$13.47	$15.06	+11.8%	+16.5%	+15.2%	+16.9%	+17.4%	+13.2%
Feb 28	Barclays	Maintains	Underweight → Underweight	—	$13.47	$15.06	+11.8%	+16.5%	+15.2%	+16.9%	+17.4%	+13.2%
Feb 24	Stephens & Co.	Maintains	Overweight → Overweight	—	$13.18	$13.36	+1.4%	+3.4%	+1.6%	-0.2%	+2.2%	+19.0%
Jan 14	Stifel	Maintains	Buy → Buy	—	$13.50	$13.78	+2.1%	+0.1%	+3.0%	+7.8%	+8.0%	+7.9%
Jan 2	Stephens & Co.	Maintains	Overweight → Overweight	—	$11.25	$11.32	+0.6%	+2.8%	+4.0%	+0.6%	+4.3%	+6.3%
Dec 3	Stephens & Co.	Upgrade	Equal Weight → Overweight	—	$12.84	$13.29	+3.5%	-2.3%	-2.5%	-5.0%	-11.3%	-11.0%
Oct 31	TD Cowen	Maintains	Buy → Buy	—	$11.73	$11.70	-0.3%	+5.7%	+10.4%	+13.3%	+13.2%	+20.6%
Oct 30	UBS	Maintains	Neutral → Neutral	—	$11.71	$11.71	+0.0%	+0.2%	+5.9%	+10.6%	+13.5%	+13.4%
Oct 30	Barclays	Maintains	Underweight → Underweight	—	$11.71	$11.71	+0.0%	+0.2%	+5.9%	+10.6%	+13.5%	+13.4%
Aug 14	Baird	Maintains	Outperform → Outperform	—	$8.49	$8.78	+3.4%	+2.1%	+1.2%	+2.5%	+1.2%	+0.0%
Aug 6	Piper Sandler	Maintains	Overweight → Overweight	—	$8.83	$9.09	+2.9%	+3.9%	-0.9%	-4.6%	-2.4%	-6.5%
Aug 6	TD Cowen	Maintains	Buy → Buy	—	$8.83	$9.09	+2.9%	+3.9%	-0.9%	-4.6%	-2.4%	-6.5%
Aug 5	Barclays	Maintains	Underweight → Underweight	—	$8.94	$8.50	-4.9%	-1.2%	+2.6%	-2.1%	-5.8%	-3.6%
Jul 26	Stifel	Maintains	Buy → Buy	—	$9.36	$9.80	+4.7%	-4.6%	-8.5%	-6.4%	-6.6%	-7.9%
May 8	Piper Sandler	Upgrade	Neutral → Overweight	—	$6.87	$7.27	+5.8%	-1.3%	+0.6%	-0.6%	+0.7%	+1.9%
May 3	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$5.26	$5.72	+8.7%	+26.0%	+28.9%	+30.6%	+28.9%	+31.4%
Apr 23	Stifel	Maintains	Buy → Buy	—	$5.01	$5.00	-0.2%	+3.4%	+3.4%	+3.0%	+4.0%	+1.4%
Mar 6	Piper Sandler	Downgrade	Overweight → Neutral	—	$5.47	$5.18	-5.3%	-1.8%	-1.5%	-1.5%	-3.1%	-7.5%
Feb 28	UBS	Maintains	Neutral → Neutral	—	$6.92	$6.55	-5.3%	-18.2%	-13.3%	-18.5%	-22.0%	-21.0%
Jan 9	Raymond James	Maintains	Strong Buy → Strong Buy	—	$9.00	$8.99	-0.1%	-1.9%	-5.4%	-8.2%	-13.0%	-18.4%
Jan 9	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$9.00	$8.99	-0.1%	-1.9%	-5.4%	-8.2%	-13.0%	-18.4%
Dec 21	UBS	Maintains	Neutral → Neutral	—	$8.06	$8.21	+1.9%	+8.4%	+7.3%	+7.9%	+8.1%	+8.4%
Nov 2	BofA Securities	Downgrade	Buy → Neutral	—	$6.66	$6.50	-2.4%	-4.7%	-9.6%	-12.3%	-7.2%	-6.2%
Oct 16	Raymond James	Upgrade	Outperform → Strong Buy	—	$6.62	$7.61	+15.0%	+17.2%	+14.7%	+11.9%	+8.9%	+7.3%
Aug 30	Morgan Stanley	Maintains	Overweight → Overweight	—	$6.01	$5.98	-0.5%	+1.2%	-2.8%	-4.3%	-3.7%	-5.7%
Jul 14	Morgan Stanley	Maintains	Overweight → Overweight	—	$5.19	$5.27	+1.5%	+3.1%	+4.2%	+5.8%	+8.5%	+11.9%
Jul 13	UBS	Maintains	Neutral → Neutral	—	$5.32	$5.30	-0.4%	-2.4%	+0.6%	+1.7%	+3.2%	+5.8%
Jul 7	JP Morgan	Maintains	Neutral → Neutral	—	$5.56	$5.51	-0.9%	+1.3%	+0.2%	+4.0%	-4.3%	-6.7%
May 1	Raymond James	Upgrade	Market Perform → Outperform	—	$6.29	$6.71	+6.7%	+8.9%	+7.8%	+5.9%	+11.3%	+9.5%
Apr 19	Goldman Sachs	Maintains	Buy → Buy	—	$5.95	$5.95	+0.0%	-11.6%	-13.9%	-10.6%	-10.1%	-8.7%
Mar 3	Goldman Sachs	Maintains	Buy → Buy	—	$7.40	$7.40	+0.0%	+2.7%	-2.6%	-6.8%	-7.0%	-12.2%

Recent Filings

8-K

Alignment Healthcare, Inc. -- 8-K Filing

Alignment Healthcare (ALHC) exceeded expectations with 33.3% revenue growth to $1.24 billion and 30.9% Medicare Advantage membership growth, raising full-year guidance across all metrics.

Apr 30

8-K

Alignment Healthcare, Inc. -- 8-K Filing

Alignment Healthcare completed a securities offering with legal opinions filed, indicating the company proceeded with a planned equity issuance under SEC registration.

Mar 4

8-K

Alignment Healthcare, Inc. -- 8-K Filing

Alignment Healthcare reported strong fourth quarter and full-year 2025 Medicare Advantage results, with CEO John Kao highlighting successful operational execution in the growing senior health insurance market.

Feb 26

Data updated apr 24, 2026 5:16pm · Source: massive.com